Resolvin D1 attenuates pulmonary hypertension by suppressing pathological connexin 43-mediated gap junctional communication in pulmonary arterial smooth muscle cells
- 1Heart Center, Qingdao Women and Children’s Hospital, Shandong University , ,
- 2Endoscopy Center, Qingdao Municipal Hospital (Qingdao Hospital, University of Health and Rehabilitation Sciences) , ,
- 3Department of Anesthesiology, Qingdao Municipal Hospital (Qingdao Hospital, University of Health and Rehabilitation Sciences) , ,
Abstract
Background: Pulmonary hypertension (PH) is characterized by progressive pulmonary vascular remodeling driven by activation of pulmonary arterial smooth muscle cells (PASMCs). Resolvin D1 (RvD1), a specialized pro-resolving lipid mediator derived from docosahexaenoic acid (DHA), has vascular protective actions; however, its pharmacological effect on connexin 43 (Cx43)-mediated gap junctional intercellular communication in PH remains unclear. This study investigated whether RvD1 attenuates PH by suppressing pathological formation of gap-junctional Cx43 (GJs-Cx43) in PASMCs.
Methods: SU5416/hypoxia-induced PH was established in C57BL/6 mice. In vitro , primary mouse PASMCs were cultured under hypoxic conditions to mimic the hypoxic pathological microenvironment and PASMCs activation associated with PH. Pulmonary hemodynamics, right ventricular function and hypertrophy, pulmonary arterial remodeling, and Cx43 distribution in isolated small pulmonary arteries were evaluated in vivo . In PASMCs, biochemical fractionation, Western blotting, immunofluorescence, lucifer yellow dye transfer, cell proliferation and migration assays, and inflammatory and oxidative stress assessments were performed. ZP1609 was used to enhance GJs-Cx43 function in vitro and in vivo .
Results: RvD1 improved pulmonary hemodynamics and right ventricular adaptation in SU5416/hypoxia-exposed mice. RvD1 also reduced pulmonary arterial wall thickening, elastic lamina remodeling, α-SMA accumulation and PCNA-positive proliferating cells. Mechanistically, SU5416/hypoxia increased total Cx43 and shifted Cx43 toward the GJs-Cx43 formation. RvD1 inhibited GJs-Cx43 formation and attenuated IL-1β, IL-6, ROS and MDA accumulation while partially restoring SOD. In primary PASMCs, hypoxia increased GJs-Cx43 expression, enhanced lucifer yellow dye transfer, and promoted proliferation and migration; these changes were suppressed by RvD1. ZP1609 restored GJs-Cx43-mediated intercellular communication and weakened the inhibitory effects of RvD1 on PASMC inflammatory activation, oxidative stress, proliferation and migration. In vivo , ZP1609 similarly blunted the protection conferred by RvD1 against pulmonary vascular remodeling, right ventricular pressure overload and right ventricular hypertrophy.
Conclusion: Pathological GJs-Cx43 formation promotes the spread of remodeling-associated signals across PASMCs networks. RvD1 limits pulmonary vascular remodeling by suppressing Cx43-dependent gap junctional communication, identifying GJs-Cx43 as a pharmacologically relevant mechanism underlying the vascular protection afforded by this DHA-derived lipid mediator.
Related
- miR-7a-5p attenuates hypoxic-ischemic encephalopathy by suppressing PARP1-mediated parthanatos
- Atractylenolide III attenuates age-related vertebral bone loss by suppressing macrophage inflammation and osteoclastogenesis
- Early infiltration of ischemia-conditioned Tregs attenuates BBB damage via suppressing neutrophil extracellular traps in ischemic stroke
- Thymol attenuates carboplatin-induced nephrotoxicity in male rats by suppressing oxidative stress and NF-κB-mediated inflammation: A biochemical and histopathological study
- Epimedium koreanum Nakai attenuates glucocorticoid-induced osteoporosis by suppressing ferroptosis via the KEAP1/NRF2/SLC7A11/GPX4 axis: comparative pharmacodynamic evaluation of four epimedium species and proteomic and metabolomic analyses of epk
BibTeX
@article{wang2026resolvin,
title = {{Resolvin D1 attenuates pulmonary hypertension by suppressing pathological connexin 43-mediated gap junctional communication in pulmonary arterial smooth muscle cells}},
author = {Hong Wang and Nan Wang and Zhixian Ji and Yanhui Zhang and Rui Dong and Silin Pan},
journal = {Frontiers in pharmacology},
year = {2026},
month = oct,
doi = {10.3389/fphar.2026.1940174},
url = {https://europepmc.org/article/PMC/PMC13671970},
note = {CC BY},
}
RIS
TY - JOUR
TI - Resolvin D1 attenuates pulmonary hypertension by suppressing pathological connexin 43-mediated gap junctional communication in pulmonary arterial smooth muscle cells
AU - Hong Wang
AU - Nan Wang
AU - Zhixian Ji
AU - Yanhui Zhang
AU - Rui Dong
AU - Silin Pan
PY - 2026
DA - 2026/10/02
JO - Frontiers in pharmacology
DO - 10.3389/fphar.2026.1940174
UR - https://europepmc.org/article/PMC/PMC13671970
AB - Background: Pulmonary hypertension (PH) is characterized by progressive pulmonary vascular remodeling driven by activation of pulmonary arterial smooth muscle cells (PASMCs). Resolvin D1 (RvD1), a specialized pro-resolving lipid mediator derived from docosahexaenoic acid (DHA), has vascular protective actions; however, its pharmacological effect on connexin 43 (Cx43)-mediated gap junctional intercellular communication in PH remains unclear. This study investigated whether RvD1 attenuates PH by suppressing pathological formation of gap-junctional Cx43 (GJs-Cx43) in PASMCs. Methods: SU5416/hypoxia-induced PH was established in C57BL/6 mice. In vitro , primary mouse PASMCs were cultured under hypoxic conditions to mimic the hypoxic pathological microenvironment and PASMCs activation associated with PH. Pulmonary hemodynamics, right ventricular function and hypertrophy, pulmonary arterial remodeling, and Cx43 distribution in isolated small pulmonary arteries were evaluated in vivo . In PASMCs, biochemical fractionation, Western blotting, immunofluorescence, lucifer yellow dye transfer, cell proliferation and migration assays, and inflammatory and oxidative stress assessments were performed. ZP1609 was used to enhance GJs-Cx43 function in vitro and in vivo . Results: RvD1 improved pulmonary hemodynamics and right ventricular adaptation in SU5416/hypoxia-exposed mice. RvD1 also reduced pulmonary arterial wall thickening, elastic lamina remodeling, α-SMA accumulation and PCNA-positive proliferating cells. Mechanistically, SU5416/hypoxia increased total Cx43 and shifted Cx43 toward the GJs-Cx43 formation. RvD1 inhibited GJs-Cx43 formation and attenuated IL-1β, IL-6, ROS and MDA accumulation while partially restoring SOD. In primary PASMCs, hypoxia increased GJs-Cx43 expression, enhanced lucifer yellow dye transfer, and promoted proliferation and migration; these changes were suppressed by RvD1. ZP1609 restored GJs-Cx43-mediated intercellular communication and weakened the inhibitory effects of RvD1 on PASMC inflammatory activation, oxidative stress, proliferation and migration. In vivo , ZP1609 similarly blunted the protection conferred by RvD1 against pulmonary vascular remodeling, right ventricular pressure overload and right ventricular hypertrophy. Conclusion: Pathological GJs-Cx43 formation promotes the spread of remodeling-associated signals across PASMCs networks. RvD1 limits pulmonary vascular remodeling by suppressing Cx43-dependent gap junctional communication, identifying GJs-Cx43 as a pharmacologically relevant mechanism underlying the vascular protection afforded by this DHA-derived lipid mediator.
SN - 1663-9812
ER -